Reviewed by Dr. Tomislav Meštrović, MD, Ph.D. The microarray is a very recent development in the field of biotechnology. Scientists are now able to understand the gene functions of any organism by ...

Microarrays have been described as a technology that will revolutionise medicine with the ultimate goal to develop effective treatments or cures for every human disease by 2050 (Ioannidis, 2005a). It ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...

Protein and peptide microarrays, the emerging tools for proteomics and clinical assays, are high-throughput methods that track binding events and activities, and decide the function of proteins on a ...

National and local leaders across government, investors, life science industry and academia acknowledge the impact of Micron’s dissolvable vaccines and therapies on human health and economic ...

Microarrays have been critical components of biomedical and clinical research strategies since their first mention in a 1995 study. Initially designed to measure gene expression, or transcription, ...

Proteomics Research and Development company, CDI Laboratories, has created glass slide substrates printed with recombinant human proteins comprising 81% of the human proteome for high-throughput ...

The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

A survey of scientists developing bioprocesses found efficiency to be the top concern, with pressure growing each year to “produce more, do it more quickly, and do so with fewer resources.” 1 Yet, ...